Listed

60 Degrees Pharmaceuticals, Inc.

SXTPNasdaqCIK 1946563HealthcareFiscal year ends Dec 31

Reports and events: 77 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

60 Degrees Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2024-07-1617:28 ET8-K5.07 Shareholder vote results0001213900-24-061853
2024-07-0915:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-060093
2024-06-2717:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-056728
2024-06-1217:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-052167
2024-05-3014:15 ETDEF 14AProxy statementPeriod 2024-07-160001213900-24-047861
2024-05-1511:56 ET10-QQuarterly reportPeriod 2024-03-310001213900-24-043323
2024-05-0216:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-039151
2024-04-0114:32 ET10-KAnnual reportPeriod 2023-12-310001213900-24-028577
2024-03-1519:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-022736
2024-02-2819:01 ET8-K3.01 Delisting notice0001213900-24-017634
2024-02-2016:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-015295
2024-02-0217:37 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001575872-24-000114
2024-01-2217:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-005352
2024-01-2215:57 ETS-1Registration statement0001213900-24-005285
2024-01-1614:56 ET8-K8.01 Other events0001213900-24-003691
2023-11-2012:41 ET10-QQuarterly reportPeriod 2023-09-300001213900-23-088610
2023-11-0316:15 ET8-K3.01 Delisting notice0001213900-23-083513
2023-10-1216:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001013762-23-003541
2023-09-1816:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-077357
2023-08-2515:26 ET10-QQuarterly reportPeriod 2023-06-300001213900-23-070884
2023-07-1716:08 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001575872-23-001173
2023-06-0816:56 ETS-1/ARegistration statement, amended0001575872-23-000911
2023-06-0114:53 ETS-1/ARegistration statement, amended0001575872-23-000882
2023-05-1915:13 ETS-1/ARegistration statement, amended0001575872-23-000790
2023-04-2816:47 ETS-1/ARegistration statement, amended0001575872-23-000644
2023-04-0317:11 ETS-1/ARegistration statement, amended0001575872-23-000507
2023-01-3117:09 ETS-1Registration statement0001575872-23-000186

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.